Partnering

GeneFluidics actively seeks strategic partners to accelerate product commercialization. Please contact us for more information.

Assay Development

GeneFluidics has a number of clinical partners for novel assay development. Non-confidential relationships include:

UCLA Department of Urology
GeneFluidics and the Department of Urology at UCLA are collaborating on the development of a rapid uropathogen screening system. The project is funded by the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health.

UCLA Department of Dental and Oral Biology
GeneFluidics and the Department of Dental and Oral Biology at UCLA are co-developing a point-of-care salivary diagnostics device, the first point-of-care device for head and neck cancer screening.

Veteran Affairs Hospital, Los Angeles
GeneFluidics and the Los Angeles VA Hospital are collaborating on the development of a rapid antibiotic suceptibility testing system. The project is funded by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

Veteran Affairs Hospital, Palo Alto, Stanford University
GeneFluidics and the Palo Alto VA Hospital are collaborating on the development of a rapid pathogen identification point-of-care system. The project is funded by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

Distribution

GeneFluidics' manual detection system products, which include sensor chips, readers, and robotic systems, are being non-exclusively distributed by Fisher Scientific.